BERLIN (dpa-AFX) - German drug distributor Celesio AG (CAKFF.PK) said Monday that it identified a non-cash impairment loss on goodwill of 80 million euros for the Brazilian wholesale activities as a result of the revaluation. This goodwill was primarily due to acquisitions in 2009 and 2011.
Celesio noted that it has conducted impairment tests due to an adjustment in the long-term earnings prospects, as part of preparing the interim financial statements as at 30 June 2014.
The company said that it will release the full interim financial statements as at 30 June 2014 on 31 July 2014.
Copyright RTT News/dpa-AFX